Related references
Note: Only part of the references are listed.Gilbert's syndrome and irinotecan toxicity: Combination with UDP-glucuronosyltransferase 1A7 variants increases
Tim O. Lankisch et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Genetic variations and haplotypes of UDP-glucuronosyltransferase 1 A locus in a Korean population
Sung Su Yea et al.
THERAPEUTIC DRUG MONITORING (2008)
Genetic diversity at the UGT1 locus is amplified by a novel 3′ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity
Hugo Girard et al.
PHARMACOGENETICS AND GENOMICS (2007)
Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer
Ken-Ichi Fujita et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
UDP-glucuronosyltransferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women
Andrew L. Hong et al.
DRUG METABOLISM AND DISPOSITION (2007)
A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3
Bertrand Caillier et al.
PHARMACOGENETICS AND GENOMICS (2007)
Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes
Can Li et al.
BMC EVOLUTIONARY BIOLOGY (2007)
The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers
E. Levesque et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Regulation of the UGT1A1 bilirubin-conjugating pathway: Role of a new splicing event at the UGT1A locus
Eric Levesque et al.
HEPATOLOGY (2007)
Gilbert's disease and atazanavir: From phenotype to UDP-glucuronosyltransferase haplotype
Tim O. Lankisch et al.
HEPATOLOGY (2006)
Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid
Olivier Bernard et al.
DRUG METABOLISM AND DISPOSITION (2006)
Navigating the HapMap
Michael R. Barnes
BRIEFINGS IN BIOINFORMATICS (2006)
Genetic Variability, Haplotypes, and htSNPs for Exons 1 at the Human UGT1A Locus
Sushma S. Thomas et al.
HUMAN MUTATION (2006)
The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver
Hugo Girard et al.
DRUG METABOLISM AND DISPOSITION (2006)
Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer
S Nagar et al.
ONCOGENE (2006)
Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone
J Thibaudeau et al.
CANCER RESEARCH (2006)
Haplotype structures of the UGT1A gene complex in a Japanese population
M Saeki et al.
PHARMACOGENOMICS JOURNAL (2006)
Comparative genomics analysis of human sequence variation in the UGT1A gene cluster
ML Maitland et al.
PHARMACOGENOMICS JOURNAL (2006)
A haplotype map of the human genome
D Altshuler et al.
NATURE (2005)
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily
PI Mackenzie et al.
PHARMACOGENETICS AND GENOMICS (2005)
The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGTIA9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients
DRJ Kuypers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 Polymorphisms (S7A, T181A, and R184S)
S Krishnaswamy et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Linkage disequilibrium patterns vary substantially among populations
SL Sawyer et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2005)
UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation
A Mori et al.
DRUG METABOLISM AND DISPOSITION (2005)
Spectrum of UGT1A1 Mutations in Crigler-Najjar (CN) Syndrome Patients: Identification of Twelve Novel Alleles and Genotype-Phenotype Correlation
Veronica Servedio et al.
HUMAN MUTATION (2005)
Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan
F Innocenti et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Variation of hepatic glucuronidation:: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4
U Ehmer et al.
HEPATOLOGY (2004)
Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity
M Iwai et al.
JOURNAL OF HUMAN GENETICS (2004)
The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk
Y Duguay et al.
CANCER RESEARCH (2004)
Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells
S Nagar et al.
PHARMACOGENETICS (2004)
Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver
H Girard et al.
PHARMACOGENETICS (2004)
Linkage disequilibrium for different scales and applications
JC Mueller
BRIEFINGS IN BIOINFORMATICS (2004)
Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (nnal) in human liver: Importance of UDP-glucuronosyltransferase 1A4
D Wiener et al.
DRUG METABOLISM AND DISPOSITION (2004)
Multiple variable first exons: A mechanism for cell- and tissue-specific gene regulation
T Zhang et al.
GENOME RESEARCH (2004)
Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium
CS Carlson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity
H Yamanaka et al.
PHARMACOGENETICS (2004)
Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs
L Villeneuve et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians
C Köhle et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilbert's syndrome
WHM Peters et al.
JOURNAL OF HEPATOLOGY (2003)
Pharmacogenomics of human UDP-glucuronosyltransferase enzymes
C Guillemette
PHARMACOGENOMICS JOURNAL (2003)
The structure of haplotype blocks in the human genome
SB Gabriel et al.
SCIENCE (2002)
Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer
CP Strassburg et al.
GUT (2002)
Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3
YH Huang et al.
PHARMACOGENETICS (2002)
Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGTIA7 gene
A Vogel et al.
GASTROENTEROLOGY (2001)
Lower-than-expected linkage disequilibrium between tightly linked markers in humans suggests a role for gene conversion
K Ardlie et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus
QH Gong et al.
PHARMACOGENETICS (2001)
A new statistical method for haplotype reconstruction from population data
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Extent and distribution of linkage disequilibrium in three genomic regions
GR Abecasis et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus:: functional consequences of three novel missense mutations in the human UGT1A7 gene
C Guillemette et al.
PHARMACOGENETICS (2000)
Share Paper
